Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 03.01.2022 1 Am J Clin Oncol 2 Ann Surg 2 Br J Cancer 1 Cancer Lett 1 Clin Cancer Res 1 Clin Res Hepatol Gastroenterol 12 Dis Colon Rectum 2 Eur J Surg Oncol 1 Gastroenterology 1 Hum Pathol 1 J Clin Oncol 1 J Natl Cancer Inst 1 J Surg Oncol 1 Oncogene 1 PLoS Genet 1 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. ULANJA MB, Beutler BD, Antwi-Amoabeng D, Moody AE, et al
   Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer: Insights from the National Inpatient Sample.
   Am J Clin Oncol. 2022;45:14-21.
   PubMed         Abstract available
   
   

   
   Ann Surg

2. POULSON M, Geary AD, Annesi C, Dechert T, et al
   The Impact of Income and Social Mobility on Colorectal Cancer Outcomes and Treatment: A Cross-sectional Study.
   Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93134.
   PubMed         Abstract available
   
   
3. PYO DH, Kim SH, Ha SY, Yun SH, et al
   Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.
   Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93132.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. GUO S, Li J, Huang Z, Yue T, et al
   The CBS-H2S axis promotes liver metastasis of colon cancer by upregulating VEGF through AP-1 activation.
   Br J Cancer. 2021 Dec 24. pii: 10.1038/s41416-021-01681.
   PubMed         Abstract available
   
   
5. ADIB E, El Zarif T, Nassar AH, Akl EW, et al
   CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
   Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01673.
   PubMed         Abstract available
   
   

   
   Cancer Lett

6. ZHONG F, Lin Y, Jing X, Ye Y, et al
   Innate tumor killers in colorectal cancer.
   Cancer Lett. 2021;527:115-126.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

7. NIXON AB, Sibley AB, Liu Y, Hatch AJ, et al
   Plasma protein markers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance).
   Clin Cancer Res. 2021 Dec 29. pii: 1078-0432.CCR-21-2389.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

8. BORIE F, Dubray V, Tretarre B
   Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis.
   Clin Res Hepatol Gastroenterol. 2021 Dec 25:101856.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

9. RUTGERS ML, Detering R, Roodbeen SX, Crolla RM, et al
   Influence of Minimally Invasive Resection Technique on Sphincter Preservation and Short-term Outcome in Low Rectal Cancer in the Netherlands.
   Dis Colon Rectum. 2021;64:1488-1500.
   PubMed         Abstract available
   
   
10. VITOUS CA, Ivatury SJ, Suwanabol PA
    Value of Qualitative Research in Colorectal Surgery.
    Dis Colon Rectum. 2021;64:1444-1446.
    PubMed        
    
    
11. JIMENEZ-RODRIGUEZ RM, Quezada-Diaz F, Hameed I, Kalabin A, et al
    Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Dis Colon Rectum. 2021;64:1463-1470.
    PubMed         Abstract available
    
    
12. LEWIS JA, Khan S, Tilney HS, Wilson JM, et al
    An Observational Analysis of a Novel Digital Rectoscope.
    Dis Colon Rectum. 2021;64:e728-e734.
    PubMed         Abstract available
    
    
13. PLIETZ MC, Kayal M, Rizvi A, Bangla VG, et al
    Slow and Steady Wins the Race: A Solid Case for a Three Stage Approach in Ulcerative Colitis.
    Dis Colon Rectum. 2021 Aug 30. pii: 00003453-900000000-99383.
    PubMed         Abstract available
    
    
14. TATAR C, Crowell KT, Sapci I, Gorgun IE, et al
    Endoscopic Submucosal Dissection in the Management of an Adenoma Within the Area of Rectal Cancer After Complete Clinical Response.
    Dis Colon Rectum. 2021;64:e717.
    PubMed        
    
    
15. KIM HJ, Choi GS
    Single-Port Robotic Low Anterior Resection With Lateral Pelvic Node Dissection in Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2021;64:e718.
    PubMed        
    
    
16. MATSUDA T, Yamashita K, Hasegawa H, Urakawa N, et al
    Two-Team Lateral Pelvic Lymph Node Dissection Assisted By the Transanal Approach.
    Dis Colon Rectum. 2021;64:e719-e724.
    PubMed         Abstract available
    
    
17. SHIRAISHI T, Sasaki T, Tsukada Y, Ikeda K, et al
    Radiological Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer after Lateral Pelvic Lymph Node Dissection.
    Dis Colon Rectum. 2021 Oct 15. pii: 00003453-900000000-99339.
    PubMed         Abstract available
    
    
18. DUDANI S, Marginean H, Gotfrit J, Tang PA, et al
    The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
    Dis Colon Rectum. 2021;64:1471-1478.
    PubMed         Abstract available
    
    
19. MARINHO A, Zalay N, Chaltiel L, Kirzin S, et al
    Oncologic and Functional Outcomes of Pelvic Perineal Reconstruction by Perineal Colostomy and Malone Procedure After Abdominoperineal Resection.
    Dis Colon Rectum. 2021;64:1501-1510.
    PubMed         Abstract available
    
    
20. GRAHAM LA, Wagner TH, Sambare TD, Hawn MT, et al
    Timing and Cost of Wound Complications After Colorectal Resection.
    Dis Colon Rectum. 2021;64:1551-1558.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

21. DUMONT F, Guenole S, Loaec C, Bourgin C, et al
    Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
    Eur J Surg Oncol. 2021 Dec 22. pii: S0748-7983(21)00995.
    PubMed         Abstract available
    
    
22. GIGLIO MC, Garofalo E, Montalti R, Vanlander A, et al
    The learning curve of laparoscopic ablation of liver tumors: A technically demanding procedure requiring dedicated training.
    Eur J Surg Oncol. 2021;47:2579-2585.
    PubMed         Abstract available
    
    

    
    Gastroenterology

23. WANG S, Gao S, Zeng Y, Zhu L, et al
    N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer.
    Gastroenterology. 2021 Dec 27. pii: S0016-5085(21)04165.
    PubMed         Abstract available
    
    

    
    Hum Pathol

24. BOCCIARELLI C, Caumont C, Samaison L, Cariou M, et al
    MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
    Hum Pathol. 2021;114:99-109.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

25. MULCAHY MF, Mahvash A, Pracht M, Montazeri AH, et al
    Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
    J Clin Oncol. 2021;39:3897-3907.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

26. WERNLY S, Datz C, Wernly B
    RE: Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Dec 25. pii: 6483088. doi: 10.1093.
    PubMed        
    
    

    
    J Surg Oncol

27. WHELAN S, Burneikis D, Kalady MF
    Rectal cancer: Maximizing local control and minimizing toxicity.
    J Surg Oncol. 2022;125:46-54.
    PubMed         Abstract available
    
    

    
    Oncogene

28. LIEBS S, Eder T, Klauschen F, Schutte M, et al
    Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities.
    Oncogene. 2021;40:5204-5212.
    PubMed         Abstract available
    
    

    
    PLoS Genet

29. MANTILLA ROJAS C, McGill MP, Salvador AC, Bautz D, et al
    Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR.
    PLoS Genet. 2021;17:e1009931.
    PubMed         Abstract available
    
    

    
    PLoS One

30. MOHAMMED M, Mboya IB, Mwambi H, Elbashir MK, et al
    Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data.
    PLoS One. 2021;16:e0261625.
    PubMed         Abstract available
    
    

    
    World J Surg

31. RAMSER M, Warschkow R, Viehl CT, Kettelhack C, et al
    The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination.
    World J Surg. 2021 Dec 27. pii: 10.1007/s00268-021-06399.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: